Aug 19, 2019

Huntsman Cancer Institute Introduces Cancer Screening and Education Bus to the Community

Huntsman Cancer Institute (HCI) at the University of Utah unveiled the Cancer Screening and Education bus. This new, state-of-the-art mobile outreach clinic brings HCI’s clinical and educational expertise and the latest screening technology to residents across Utah, including those who live in distant geographic areas and rural communities. The mobile outreach vehicle is a collaboration between HCI and University of Utah Health (U of U Health) and will offer health education and screening services for breast cancer and skin cancer.

Aug 15, 2019

Discovery of How Cells Override Genetic Changes Could Lead to New Approaches in Pancreatic Cancer Treatment

Pancreatic cancer is one of the deadliest cancers. It is difficult to diagnose, is often not found until it has spread to other parts of the body, and is mostly untreatable. A discovery by scientists at Huntsman Cancer Institute at the University of Utah could lead researchers to a more effective way to treat pancreatic cancer.

Aug 01, 2019

BRIGHT Study Finds Genetic Testing Motivates Behavior Changes in Families at Risk for Melanoma

Skin cancer is the most commonly diagnosed cancer in the United States, and melanoma is the most severe type of skin cancer. Utah has a particularly high melanoma rate. A new study led by researchers at Huntsman Cancer Institute collaborators at Northwestern University and Oregon Health and Science University investigated whether genetic testing would motivate people at risk of developing melanoma to alter their behavior in order to reduce their risk.

Jul 18, 2019

Huntsman Cancer Institute Researchers Develop Potential New Treatment for MYC-driven Small Cell Lung Cancer

Lung cancer is the leading cause of cancer death among men and women in Utah and the United States. Often, symptoms do not appear until the disease is advanced. Therefore, research studies toward better practices to prevent, find, and treat lung cancer are paramount. Research from scientists at Huntsman Cancer Institute yielded new insights into understanding potential new treatment options for MYC-driven tumors, a distinct subtype of small cell lung cancer.

Jul 09, 2019

Possible ‘Achilles Heel’ Discovered in Developing Better Drug Treatment in Cancers with Overactive Smoothened Protein

One of the most significant obstacles cancer patients face is resistance to drug treatment. Aggressive tumors often become adept at resisting the powerful drugs used to combat them. Therapeutic agents that were effective at one point may become ineffective as a patient’s tumor evolves and learns to fight the drug. A recent discovery could lead to a better understanding of how cancer patients develop drug resistance.

Jul 03, 2019

Huntsman Cancer Institute Researchers Discover Melanoma Can Spread without Tumor Growth

Utah has the highest rate of melanoma in the United States. Melanoma is an aggressive skin cancer that spreads quickly. Allie Grossmann, MD, PhD, focuses on identifying better ways to treat this lethal cancer. In a study recently published by the journal Cancer Research, Grossmann details one of the factors behind how and why melanoma metastasizes so quickly.

Jul 01, 2019

Sigma Chi Fraternity Pledges $20 Million Dedicated to Women's Cancer Research

Last week, Sigma Chi International Fraternity announced a new $20-million pledge to Huntsman Cancer Foundation, dedicated to and used for women’s cancer research, treatment and wellness at Huntsman Cancer Institute.

Jun 19, 2019

Huntsman Cancer Institute Research Discovery Leads to New Clinical Trial for Myelofibrosis Patients

Researchers at Huntsman Cancer Institute at the University of Utah discovered in laboratory studies that an experimental drug called selinexor may block a crucial survival pathway exploited by myelofibrosis cells.